Abstract: This invention relates to a mutant E. coli heat-labile enterotoxin (LT) subunit A that can be used as an adjuvant. This subunit A mutant contains an amino acid substitution at a position corresponding to position 61 of a wild-type LT. An LT containing this mutated subunit A exhibits reduced toxicity compared to its wild type counterpart.
Abstract: This invention relates to a mutant E. coli heat-labile enterotoxin (LT) subunit A that can be used as an adjuvant. This subunit A mutant contains an amino acid substitution at a position corresponding to position 61 of a wild-type LT. An LT containing this mutated subunit A exhibits reduced toxicity compared to its wild type counterpart.
Abstract: The present invention relates to the collection of alkalophilic/alkaline-tolerant microbes and use of said microbes in water glass wastewater treatment. The wastewater is treated directly with alkalophilic/alkaline-tolerant microbes cultured on granular activated carbon without any prior pH adjustment. Subsequently, water glass is separated from the biotreated water by lowering its pH. Alternatively, water glass is separated from biotreated water by distilling the water as water and water glass have different boiling points.
Type:
Grant
Filed:
October 23, 2003
Date of Patent:
February 26, 2008
Assignee:
Development Center for Biotechnology
Inventors:
Ru-rong Wu Hsiao, Mei-hsien Yeh, Hsiu-ping Pearl Lin
Abstract: An aqueous inhalation pharmaceutical composition comprising a polypeptide or protein is provided. The composition of the present invention can improve the bioavailability of the polypeptide and protein, and avoid inducing toxicity in the lung.
Type:
Application
Filed:
May 25, 2006
Publication date:
June 21, 2007
Applicant:
Development Center For Biotechnology
Inventors:
Pao-Nien Chen, Shyh-Fong Chen, Shu-Chien Liu, Fan-Jung Liu
Abstract: A solid phase synthesis method for preparing peptide-spacer-lipid conjugates, the peptide-spacer-lipid conjugates synthesized by the method, and liposomes containing the peptide-spacer-lipid conjugates. The present invention provides a convenient solid phase synthesis method for preparing peptide-spacer-lipid conjugates and provides various linkage groups (such as amide group) for conjugating peptide, spacer and lipid, wherein the spacer may comprise PEG. Several advantages can be achieved, such as the synthetic procedure can be simplified, the synthesis process can be set to automation, the purification is easier in each reaction step, and the product losses can be reduced to minimal during synthesis.
Abstract: Antigenic fragments of human T-lymphotropic virus (HTLV), their fusion proteins with glutathione S-tranferase (GST) or thioredoxin (Thio), and a process for producing the fusion proteins thereof. The antigenic fragment of HTLV comprises the amino acid sequence of SEQ ID Nos: 3 or 4.
Abstract: A new method for the preparation of chiral 4-substituted 2-piperidinones, trans-3,4-disubstituted 2-piperidinones, and trans-3,4-disubstituted piperidines is invented. Chiral paroxetine can be obtained from a chiral trans-3,4-disubstituted piperidine intermediate in high purity and good selectivity.
Type:
Grant
Filed:
May 28, 2002
Date of Patent:
December 21, 2004
Assignee:
Development Center for Biotechnology
Inventors:
Lee Tai Liu, Hsiang-Ling Huang, Pao-Chiung Hong, Shyh-Fong Chen
Abstract: The present invention relates to an interference-eliminating membrane for use in detecting uric acid in a sample, comprising a compound for inhibiting or shading uric acid interfering substances, or derivatives thereof, and a carrier having an absorption property and permeability for the sample; and a process for preparing the interference-eliminating membrane.
The present invention also provides a test strip for use in detecting uric acid in a sample, comprising a reagent reaction layer or optional interference-eliminating membranes and/or support layers; and a kit comprising the test strip of the invention.
Type:
Grant
Filed:
May 26, 2000
Date of Patent:
March 2, 2004
Assignee:
Development Center for Biotechnology
Inventors:
Tsai Yun Lee, Yi Chih Lei, Shi-Yuan Sheu, Yu Fen Tsai, Tai-Guang Wu, Hung-Hsiu Ho, Ming-Yen Kuo, Jiuan J. Liu, Tong H. Chang, Hsueh-Fang Chen, Liahng-Yirn Liu
Abstract: A solid phase synthesis method for preparing peptide-spacer-lipid conjugates, the peptide-spacer-lipid conjugates synthesized by the method, and liposomes containing the peptide-spacer-lipid conjugates. The present invention provides a convenient solid phase synthesis method for preparing peptide-spacer-lipid conjugates and provides various linkage groups (such as amide group) for conjugating peptide, spacer and lipid, wherein the spacer may comprise PEG. Several advantages can be achieved, such as the synthetic procedure can be simplified, the synthesis process can be set to automation, the purification is easier in each reaction step, and the product losses can be reduced to minimal during synthesis.
Abstract: The invention relates to nucleic acids containing a nucleotide sequence encoding a polypeptide, the polypeptide having (1) the P2 and P3 regions of a swine vesicular disease virus polyprotein, and (2) an amino acid sequence heterologous to the polyprotein. The invention also includes methods of preparing such nucleic acids (e.g., RNA or DNA expression vectors) and methods of using such nucleic acids to express RNA or protein.
Type:
Grant
Filed:
October 6, 2000
Date of Patent:
September 9, 2003
Assignee:
Development Center for Biotechnology
Inventors:
Ching-Long Hwong, Cheng-Kai Lo, Lung-Shen Lin, Li-Yen Edward Chang
Abstract: The present invention discloses a diagnostic kit for assaying a cell presenting specific surface specific antigen, comprising: a first complex, comprising a magnetic bead coated with a first ligand specific to the specific cell surface antigen; a second complex, comprising a second ligand specific to the common cell surface antigen and a signal generation means; and a magnetic support. The kit can be used for the quantitative and qualitative analysis of a cell sample containing specific cell surface antigen.
Type:
Application
Filed:
November 19, 2001
Publication date:
June 13, 2002
Applicant:
Development Center for Biotechnology, a Taiwan corporation
Abstract: The present invention relates to mutant D-amino acid aminotransferase, including nucleic acids encoding mutant D-amino acid aminotransferase. The mutant D-amino acid aminotransferase of the present invention is obtained by the substitution of the glutamate residue at position 13 of wild type D-amino acid aminotransferase from Bacillus sphaericus with hydrophobic amino acids. The mutant D-amino acid aminotransferase can be used in the production of D-amino acid and the conversion of glutaryl-7-aminocephalosporanic acid from cephalosporin C. The present invention also includes replica-paper staining method for screening the cells expressing high DAT activity.
Abstract: The present invention provides a process for preparing an amide, which comprises reacting an amine with an ester in a molten form in the absence of a solvent.
Type:
Grant
Filed:
July 8, 1998
Date of Patent:
November 6, 2001
Assignee:
Development Center for Biotechnology
Inventors:
Wen-Chih Chou, Chang-Wei Tan, Shyh-Fong Chen, Hao Ku
Abstract: The present invention relates to a process for the preparation of amides, comprising reacting amines with carboxylic acids in the presence of silicon amines. The present invention further relates to a process for the preparation of quinazoline derivatives, comprising reacting amines with carboxylic acids in the presence of silicon amines to obtain amides and contacting the resultant amides with quinazoline.
Abstract: The invention relates to isolates of Streptomyces orientalis Y31014 and Streptomyces melanogenes Y31042-1 can be effectively control whiteflies.
The invention also concerns a novel biopesticide and its use to control pests.
Abstract: The present invention describes a peptide and analogs thereof which is a fragment of an olfactory receptor protein capable of selectively binding to trimethylamine so that they are useful for detecting trimethylamine. The present invention further describes a method and a device for detecting trimethylamine by using the peptide and the analogs thereof.
Abstract: The invention relates to isolates of Streptomyces orientalis Y31014 and Streptomyces melanogenes Y31042-1 can be effectively control whiteflies.
The invention also concerns a novel biopesticide and its use to control pests.
Abstract: The present invention provides sustained release oral solid dosage forms of cisapride by using a multi-particulate system, which are bioavailable and can provide efficient blood level of cisapride over 24 hours. Unit dosage forms of cisapride which comprise a plurality of substrates containing sustained release cisapride, as well as pharmaceutical compositions containing the dosage forms, are also disclosed herein.
Type:
Grant
Filed:
July 7, 1999
Date of Patent:
April 24, 2001
Assignee:
Development Center for Biotechnology
Inventors:
Shouchung Chao, Wen-Pao Tseng, Hui-Fang Chang, David Chen, Shu-Bin Lu
Abstract: The present invention describes a peptide and analogues thereof, which is a fragment of an olfactory receptor protein capable of selectively binding to trimethylamine so that they are useful for detecting trimethylamine.
The present invention further describes a method and a device for detecting trimethylamine by using the peptide and the analogues thereof.